Skip to main content

Table 5 Application of the proposed approaches for the determination of adapalene in its pharmaceutical Adapalene® gel

From: Determination of adapalene in gel formulation by conventional and derivative synchronous fluorimetric approaches. Application to stability studies and in vitro diffusion test

Parameter

Amount taken (ng/mL)

First approach at 389 nm

Second approach

Comparisonmethod [3]

 

Amount found (ng/mL)

% found

Amount found (ng/mL)

% found

Amount

found

(µg/mL)

 % found

SDSF at 346 nm

FDSF at 312.45 nm

SDSF at 346 nm

FDSF at 312.45 nm

Adapalene® gela

6.0

5.957

99.28

5.932

6.072

98.87

101.20

20.0

100.07

(0.1 % ADP)

8.0

8.082

101.03

7.922

8.026

99.03

100.33

30.0

98.80

Batch # 011371

10.0

10.007

100.07

10.022

9.905

100.22

99.05

40.0

101.03

 

12.0

11.900

99.17

11.972

11.986

99.77

99.88

  

Mean

  

99.89

  

99.47

100.12

 

99.97

S.D.

  

0.86

  

0.63

0.90

 

1.12

t

  

0.11

  

0.75

0.19

  

F

  

1.69

  

3.11

1.56

  
  1. N.B. Each result is the average of three separate determinations
  2. The tabulated t and F values are 2.57 and 9.55, respectively at P = 0.05 [15]
  3. aProduct of Borg Pharmaceutical Ind., Alexandria, Egypt